US pharma company fined $435 million

Por McLaughlin, Paul
Publicado em 2006

Viral Hepatitis Vaccination in an Opioid Treatment Program: Hartford, Connecticut, 2002–2005

Por McLaughlin, Paul
Publicado em 2007

Contraband cigarettes becoming a national norm

Por McLaughlin, Paul
Publicado em 2007

Swiss medical technology industry gobbling up market share

Por McLaughlin, Paul
Publicado em 2011

Use of Coercive Measures during Involuntary Psychiatric Admission and Treatment Outcomes: Data from a Prospective Study across 10 European Countries

Por McLaughlin, Paul, Giacco, Domenico, Priebe, Stefan
Publicado no PLoS One (2016)

Methylation: lost in hydroxylation?

Por Trewick, Sarah C., McLaughlin, Paul J., Allshire, Robin C.
Publicado em 2005

HLA-DR regulation and the influence of GM-CSF on transcription, surface expression and shedding

Por Perry, Sara E, Mostafa, Sobhy M, Wenstone, Richard, Shenkin, Alan, McLaughlin, Paul J
Publicado em 2004

Invadolysin: a novel, conserved metalloprotease links mitotic structural rearrangements with cell migration

Por McHugh, Brian, Krause, Sue A., Yu, Bin, Deans, Anne-Marie, Heasman, Sarah, McLaughlin, Paul, Heck, Margarete M.S.
Publicado em 2004

Translation of the Risk Avoidance Partnership (RAP) for Implementation in Outpatient Drug Treatment Clinics

Por Weeks, Margaret R., Kostick, Kristin, Li, Jianghong, Dunn, Jennifer, McLaughlin, Paul, Richmond, Phil, Choudhury, Shonali, Obidoa, Chinekwu, Mosher, Heather, Martinez, Maria
Publicado no J Psychoactive Drugs (2015)

A NASP (N1/N2)-Related Protein, Sim3, Binds CENP-A and Is Required for Its Deposition at Fission Yeast Centromeres

Por Dunleavy, Elaine M., Pidoux, Alison L., Monet, Marie, Bonilla, Carolina, Richardson, William, Hamilton, Georgina L., Ekwall, Karl, McLaughlin, Paul J., Allshire, Robin C.
Publicado em 2007

Treatment Retention among Patients Randomized to Buprenorphine/Naloxone Compared to Methadone in A Multi-site Trial

Por Hser, Yih-Ing, Saxon, Andrew J., Huang, David, Hasson, Al, Thomas, Christie, Hillhouse, Maureen, Jacobs, Petra, Teruya, Cheryl, McLaughlin, Paul, Wiest, Katharina, Cohen, Allan, Ling, Walter
Publicado em 2013

Patient Perspectives on Buprenorphine/Naloxone: A Qualitative Study of Retention During the Starting Treatment with Agonist Replacement Therapies (START) Study

Por Teruya, Cheryl, Schwartz, Robert P., Mitchell, Shannon Gwin, Hasson, Albert L., Thomas, Christie, Buoncristiani, Samantha H., Hser, Yih-Ing, Wiest, Katharina, Cohen, Allan J., Glick, Naomi, Jacobs, Petra, McLaughlin, Paul, Ling, Walter
Publicado no J Psychoactive Drugs (2014)

From Research to the Real World: Buprenorphine in the Decade of the Clinical Trials Network

Por Ling, Walter, Jacobs, Petra, Hillhouse, Maureen, Hasson, Albert, Thomas, Christie, Freese, Thomas, Sparenborg, Steven, McCarty, Dennis, Weiss, Roger, Saxon, Andrew, Cohen, Allan, Straus, Michele, Brigham, Gregory, Liu, David, McLaughlin, Paul, Tai, Betty
Publicado em 2010

Long-term Outcomes after Randomization to Buprenorphine/Naloxone versus Methadone in A Multi-site Trial

Por Hser, Yih-Ing, Evans, Elizabeth, Huang, David, Weiss, Robert, Saxon, Andrew, Carroll, Kathleen M., Woody, George, Liu, David, Wakim, Paul, Matthews, Abigail G., Hatch-Maillette, Mary, Jelstrom, Eve, Wiest, Katharina, McLaughlin, Paul, Ling, Walter
Publicado no Addiction (2016)

Effectiveness of HIV/STD Sexual Risk Reduction Groups for Women in Substance Abuse Treatment Programs: Results of a NIDA Clinical Trials Network Trial

Por Tross, Susan, Campbell, Aimee N. C., Cohen, Lisa R., Calsyn, Donald, Pavlicova, Martina, Miele, Gloria, Hu, Mei-Chen, Haynes, Louise, Nugent, Nancy, Gan, Weijin, Hatch-Maillette, Mary, Mandler, Raul, McLaughlin, Paul, El-Bassel, Nabila, Crits-Christoph, Paul, Nunes, Edward V.
Publicado em 2008

Buprenorphine/Naloxone and Methadone Effects on Laboratory Indices of Liver Health: a Randomized Trial

Por Saxon, Andrew J., Ling, Walter, Hillhouse, Maureen, Thomas, Christie, Hasson, Albert, Ang, Alfonso, Doraimani, Geetha, Tasissa, Gudaye, Lokhnygina, Yuliya, Leimberger, Jeff, Bruce, R. Douglas, McCarthy, John, Wiest, Katharina, McLaughlin, Paul, Bilangi, Richard, Cohen, Allan, Woody, George, Jacobs, Petra
Publicado em 2012

The RNA-Editing Enzyme ADAR1 Controls Innate Immune Responses to RNA

Por Mannion, Niamh M., Greenwood, Sam M., Young, Robert, Cox, Sarah, Brindle, James, Read, David, Nellåker, Christoffer, Vesely, Cornelia, Ponting, Chris P., McLaughlin, Paul J., Jantsch, Michael F., Dorin, Julia, Adams, Ian R., Scadden, A.D.J., Öhman, Marie, Keegan, Liam P., O’Connell, Mary A.
Publicado no Cell Rep (2014)

Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature

Por Rice, Gillian I, Kasher, Paul R, Forte, Gabriella M A, Mannion, Niamh M, Greenwood, Sam M, Szynkiewicz, Marcin, Dickerson, Jonathan E, Bhaskar, Sanjeev S, Zampini, Massimiliano, Briggs, Tracy A, Jenkinson, Emma M, Bacino, Carlos A, Battini, Roberta, Bertini, Enrico, Brogan, Paul A, Brueton, Louise A, Carpanelli, Marialuisa, Laet, Corinne De, de Lonlay, Pascale, del Toro, Mireia, Desguerre, Isabelle, Fazzi, Elisa, Garcia-Cazorla, Àngels, Heiberg, Arvid, Kawaguchi, Masakazu, Kumar, Ram, Lin, Jean-Pierre S-M, Lourenco, Charles M, Male, Alison M, Marques, Wilson, Mignot, Cyril, Olivieri, Ivana, Orcesi, Simona, Prabhakar, Prab, Rasmussen, Magnhild, Robinson, Robert A, Rozenberg, Flore, Schmidt, Johanna L, Steindl, Katharina, Tan, Tiong Y, van der Merwe, William G, Vanderver, Adeline, Vassallo, Grace, Wakeling, Emma L, Wassmer, Evangeline, Whittaker, Elizabeth, Livingston, John H, Lebon, Pierre, Suzuki, Tamio, McLaughlin, Paul J, Keegan, Liam P, O’Connell, Mary A, Lovell, Simon C, Crow, Yanick J
Publicado em 2012